Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Rare Disease Precision Panel > Stickler Syndrome Precision Panel

Stickler Syndrome Precision Panel

Stickler Syndrome (SS), also known as hereditary arthroophthalmopathy belongs to the group of connective tissue disorders together with Marshall syndrome, and so have overlapping characteristics.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Stickler Syndrome (SS), also known as hereditary arthroophthalmopathy belongs to the group of connective tissue disorders together with Marshall syndrome, and so have overlapping characteristics. It is caused by mutations of genes in charge of the assembly of collagen. Since collagen is a major component of cartilage, vitreous and nucleus pulposus the clinical manifestations will affect these structures. Affected individuals are at significantly increased risk for retinal detachment and blindness, and early detection and diagnosis are critical in improving visual outcomes of these patients. The mode of inheritance varies from autosomal dominant, recessive and X-linked. 

  • The Igenomix Stickler Syndrome Precision Panel can be used to make a directed and accurate diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

  • The Igenomix Stickler Syndrome Precision Panel is indicated for those patients with a clinical diagnosis or suspicion with or without the following manifestations: 
    • Orofacial abnormalities: midfacial underdevelopment and cleft palate 
    • Ophthalmologic abnormalities: myopia, cataract, retinal detachment 
    • Hearing loss 
    • Precocious arthritis  

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team in the form of surgical repair of orofacial abnormalities, retinal detachment, hearing and visual aids and symptomatic medical treatment for arthropathy. Early and continuous ophthalmologic examination follow-up to prevent further complications.  
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation.  

Genes & Diseases

Methodology

References

See scientific referrals

Cervelli, V., Bottini, D., Grimaldi, M., Gentile, P., Caruso, R., & Gravante, G. (2008). The Stickler syndrome. A genetic disease with clinical implications for the plastic surgeon. Journal Of Plastic, Reconstructive & Aesthetic Surgery, 61(8), 987-988. doi: 10.1016/j.bjps.2007.11.059 

Richards, A., McNinch, A., Martin, H., Oakhill, K., Rai, H., & Waller, S. et al. (2010). Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1. Human Mutation, 31(6), E1461-E1471. doi: 10.1002/humu.21257 

Stickler Syndrome. (2021). Retrieved 31 March 2021, from http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK1302/ 

Boothe, M., Morris, R., & Robin, N. (2020). Stickler Syndrome: A Review of Clinical Manifestations and the Genetics Evaluation. Journal of personalized medicine, 10(3), 105. https://doi.org/10.3390/jpm10030105 

Robin, N. H., Moran, R. T., & Ala-Kokko, L. (2000). Stickler Syndrome. In M. P. Adam (Eds.) et. al., GeneReviews®. University of Washington, Seattle. 

Rishi, P., Maheshwari, A., & Rishi, E. (2015). Stickler syndrome. Indian journal of ophthalmology, 63(7), 614–615. https://doi.org/10.4103/0301-4738.167114 

Aylward, B., daCruz, L., Ezra, E., Sullivan, P., MacLaren, R. E., Charteris, D., Gregor, Z., Bainbridge, J., & Minihan, M. (2008). Stickler syndrome. Ophthalmology, 115(9), 1636–1638. https://doi.org/10.1016/j.ophtha.2008.04.018 

 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information